glp-1 kaiser 📌 Starting January 1, 2025, Permanente will be making adjustments to the coverage of drugs and other Anti-Obesity Medications (AOMs) in California commercial plans. For members with a BMI less kaiser permanente glp-1 coverage policy

Key highlights: Once-daily oral administration No food or water restrictions No injections required ~12% mean weight loss in Phase 3 trials Improvements in cardiometabolic risk markers Indication: Approved for adults with obesity, or overweight individuals with weight-related comorbidities, alongside reduced-calorie diet and increased physical activity

I dont think of this as a performance-enhancing drug in the same way as EPO or an anabolic steroid, McGuire says

a clenched fist of cooked lentils or beans provides around 15 to 20 grams

: ( 130 100 ) ( 50 100 ) ( 40 100 ) ( 20 100 )

Also, a new instrument, the Parent Global Impressions (PGI) was used at the end of the study to evaluate changes in symptoms

We have to be measured in our science